Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT03271697
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 120 participants
- Registry
-
NCT03271697
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT03271697. Randomized; triple masking; primary purpose treatment. Start 2017-09 (anticipated); primary completion 2020-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage
- Acronym
- AMASH
- Condition
- Aneurysmal Subarachnoid Hemorrhage
- Intervention (Drug)
- Astragalus Membranaceus
- Intervention (Drug)
- Placebo
- Lead sponsor
- China Medical University Hospital
Record details
- Record id
cardio:ct-nct03271697- Content hash
c50501863618e557495c3168f137c9a827e5f13643ff8e5f1de355a622685ccf